Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) EBT Margin (2016 - 2025)

United Therapeutics (UTHR) has disclosed EBT Margin for 17 consecutive years, with 56.19% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 507518.0% to 56.19% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 53.85% through Dec 2025, down 1828.0% year-over-year, with the annual reading at 53.85% for FY2025, 36.0% up from the prior year.
  • EBT Margin hit 56.19% in Q4 2025 for United Therapeutics, up from 54.78% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 29540.0% in Q4 2023 to a low of 5018.99% in Q4 2024.
  • Historically, EBT Margin has averaged 1270.06% across 5 years, with a median of 52.6% in 2024.
  • Biggest five-year swings in EBT Margin: soared 2950362bps in 2023 and later plummeted -3455899bps in 2024.
  • Year by year, EBT Margin stood at 33.84% in 2021, then grew by 8bps to 36.38% in 2022, then skyrocketed by 81102bps to 29540.0% in 2023, then tumbled by -117bps to 5018.99% in 2024, then soared by 101bps to 56.19% in 2025.
  • Business Quant data shows EBT Margin for UTHR at 56.19% in Q4 2025, 54.78% in Q3 2025, and 51.14% in Q2 2025.